Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 6/10/13 → 2/27/25 |
Financiación
- Eisai Incorporated: 932.727,00 US$
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer#s Disease
- Jicha, Gregory (PI)
- Caban-Holt, Allison (Former CoI)
- Smith, Charles (Former CoI)